Overall survival of patients with relapsed and refractory multiple myeloma: adjusting for crossover in the MM-003 trial for pomalidomide plus low-dose dexamethasone vs. high-dose dexamethasone — Gillian Morgan (2014) | RDL Network
Overall survival of patients with relapsed and refractory multiple myeloma: adjusting for crossover in the MM-003 trial for pomalidomide plus low-dose dexamethasone vs. high-dose dexamethasone
Gareth J. Morgan, Antonio Palumbo, Sujith Dhanasiri, Dawn Lee, Katja Weisel, Thierry Façon, Michel Delforge, Albert Oriol, Mohamed H. Zaki, Xin Yu, Lars Sternås, Christian Jacques, Ron Akehurst, Fritz Offner, Meletios A Dimopoulos
Meletios A Dimopoulos, Katja Weisel, Kevin Song, Michel Delforge, Lionel Karlin, Hartmut Goldschmidt, Philippe Moreau, A. Baños, Albert Oriol, Laurent Garderet, Michèle Cavo, Иванова, Adrían Alegre, Joaquín Martínez‐López, C. I Chen, A. Spencer, Stefan Knop, NJ Bahlis, C. Renner, Xiaoyan Yu, Kelvin Hong,
Jesús F. San Miguel, Katja Weisel, Philippe Moreau, Martha Q. Lacy, Kevin Song, Michel Delforge, Lionel Karlin, Hartmut Goldschmidt, Anne Banos, Albert Oriol, Adrían Alegre, Christine Chen, Michèle Cavo, Laurent Garderet, Valentina Ivanova, Joaquín Martínez‐López, Andrew R. Belch, Antonio Palumbo, Stephen Schey, Pieter Sonneveld, Xin Yu, Lars Sternås,
Kevin Song, Meletios A Dimopoulos, Katja Weisel, Philippe Moreau, Antonio Palumbo, Andrew Belch, Stephen Schey, Pieter Sonneveld, Lars Sternås, Xiaoyan Yu, Ramesh Amatya, Mara Silvia Monzini, Mohamed H. Zaki, Christian Jacques, Jesús F. San Miguel
Hartmut Goldschmidt, Meletios A Dimopoulos, Katja Weisel, Philippe Moreau, Martha Q. Lacy, Kevin Song, Michel Delforge, Lionel Karlin, Anne Banos, Albert Oriol Rocafiguera, Xin Yu, Lars Sternås, Christian Jacques, Mohamed H. Zaki, Jesús F. San Miguel
Discussion(0)
No comments yet. Be the first to comment.